NCT00021164View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Metastatic Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2001

Study Completion Date

May 31, 2004

Conditions
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

incomplete Freund's adjuvant

BIOLOGICAL

telomerase: 540-548 peptide vaccine

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00021164 - Vaccine Therapy in Treating Patients With Metastatic Cancer | Biotech Hunter | Biotech Hunter